A

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

IT Product Owner for Scientific Solutions

Product ManagementConfirmed live in the last 24 hours
Full-timeHellerup, DenmarkNo salary listed

About the Job

Requirements

  • Hold a relevant academic degree at minimum master's degree level.
  • Have 5+ years of experience in a related role within a pharmaceutical, biotechnology, or comparable scientific environment.
  • Have a background that enables understanding of the translational stage of drug development.
  • Have hands-on experience managing and developing a technology product portfolio.
  • Have experience with product discovery and decision facilitation.
  • Have experience driving the successful delivery of digital products and platforms.
  • Have experience working in an agile team and continuously improving ways of working.
  • Submit the application in English.

Responsibilities

  • Ensure that a broad scientific user group has coherent technology offerings across applications, tools, and data that evolve with their needs.
  • Communicate closely and frequently with users and leadership teams to create a clear, shared understanding of the most important needs and priorities.
  • Translate business needs into technology deliverables and coordinate with relevant IT teams to ensure prioritization and completion.
  • Prioritize and manage the Scientific Solutions team’s backlog and actively help remove impediments to technology delivery.
  • Collaborate closely with other teams across Global IT to manage dependencies and align priorities.

About the Company

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Ascendis Pharma uses its TransCon technology to create long-acting prodrugs for rare endocrine diseases, with expansions into oncology and ophthalmology. The platform temporarily attaches an unmodified drug to an inert carrier and releases the active drug in a predictable, sustained way after injection, reducing how often patients must dosing. It differentiates itself through a proprietary delivery system and a track record that includes marketed therapies like SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for hypoparathyroidism, along with collaborations such as a Novo Nordisk deal. The company aims to improve patient outcomes by enabling easier, less frequent dosing while expanding its pipeline across rare endocrine diseases, cancer, and eye diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
2007

Recently Posted Jobs

Explore more opportunities at Ascendis Pharma

See more jobs